Home » Posts tagged with » Active pharmaceutical ingredients
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business

Novartis’ Sandoz to acquire Aspen’s Japanese pharma business

Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen Pharmacare in a deal valued up to €400 million, as per the latest pharma acquisition news. The acquisition includes shares in Aspen Japan and associated assets held by the South […]

Mallinckrodt to sell Canadian CDMO BioVectra to H.I.G. Capital for $250m

Mallinckrodt sale of BioVectra to H.I.G. Capital : Irish biopharma company Mallinckrodt has agreed to divest its wholly-owned subsidiary BioVectra, a Canadian CDMO (contract development and manufacturing organization) to an affiliate of H.I.G. Capital for nearly US$250 million, as per the latest pharma acquisition news. The transaction amount to be paid by H.I.G. Capital, which is […]

Continue reading …
US pharma manufacturer Conagen acquires glycoproteins production platform

US pharma manufacturer Conagen has purchased a glycoproteins production platform – a fermentation-based technology for the production of glycoproteins used for making therapeutics, for an undisclosed price. The acquisition made from an undisclosed seller includes various patents covering the glycoproteins production platform and all related tangible assets, which are expected to place Conagen among the […]

Continue reading …
Italian CDMO Olon wraps up acquisition of Mahad API plant in India

Mahad API plant acquisition : Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has completed the acquisition of an API manufacturing facility in Mahad in Maharashtra, India. The company’s subsidiary Olon India will initiate all the activities the next April 1st as per the strategy of Olon after an intensive transition period that […]

Continue reading …
Italian CDMO Olon acquires API manufacturing plant in India

Olon, an Italy-based active pharmaceutical ingredients (API) developer and manufacturer, has acquired a generics chemical operations API manufacturing plant in Mahad in the Indian state of Maharashtra. According to Olan CEO Paolo Tubertini, the acquisition of AP manufacturing facility in India will give the company scope to speed up growth by adding new CDMO projects […]

Continue reading …